Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenImmigration
  • OpenSubsidies
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Meningococcal Conjugate (Menactra)
  4. Facial paresis
Meningococcal Conjugate (Menactra)×Facial paresis

Facial paresis Reports for Meningococcal Conjugate (Menactra)

#386 most reported symptom for this vaccine

37
Reports
0
Deaths
17
Hospitalizations
0
Mortality Rate
%
45.9
Hosp. Rate
%

Facial paresis and Meningococcal Conjugate (Menactra)

Facial paresis has been reported 37 times in association with Meningococcal Conjugate (Menactra) vaccination in VAERS. This represents 0.1% of all 36,149 reports for this vaccine.

Among these reports, 0 mentioned death (0.00%) and 17 involved hospitalization (45.9%).

Facial paresis is the #386 most frequently reported symptom for Meningococcal Conjugate (Menactra) out of 1843 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 37 reports of Facial paresis after Meningococcal Conjugate (Menactra) vaccination may seem alarming, but context is critical.

The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.

Important Context

•Association, not causation: These reports show Facial paresis occurred after vaccination, not that the vaccine caused it.
•Background rates: Facial paresis may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Dysuria37 reportsRespiratory rate increased37 reportsStreptococcal identification test negative37 reportsBlood culture37 reports

Quick Facts

Reports:37
Deaths:0
Hospitalizations:17
% of Vaccine:0.1%
Rank:#386 of 1843

Related Pages

Meningococcal Conjugate (Menactra) OverviewFacial paresis (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.